Is a complete ANIK research report available?

No complete published report is available for Anika Therapeutics, Inc. (ANIK) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Anika Therapeutics, Inc. (ANIK)

NASDAQ: ANIK · USD

$18.1

+1.90 (+11.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ANIK analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	241.8M
Revenue (ttm)	120.7M
Net income (ttm)	-3.8M
EPS (ttm)	-$0.28
Shares out	13.4M
Volume	114,412
Beta	0.23
Price target	$21.0	+16.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 120.7M
Net income (ttm): -3.8M
EPS (ttm): -$0.28
Market cap: 241.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ANIK indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000898437
Company name	Anika Therapeutics, Inc.
Country	United States
Country code	US
Cusip	035255108
Employees	235
Employees Change	-53%
Employees Change Percent	-18.4
Enterprise value	$226.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	114.9
Industry PE Fwd	13.93
IPO Date	1993-04-29
Isin	US0352551081
Last refreshed	2026-07-31
Market cap	$241.8M
Market cap category	Micro-Cap
Price	$18.07
Price currency	USD
Rev Per Employee	513,421.28x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	3841
Symbol	ANIK
Website	https://www.anika.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.56%
EV Sales Forward	1.86x
EV/EBITDA	442.84x
EV/FCF	403.44x
EV/Sales	1.88x
FCF yield	0.23%
P/B ratio	1.75x
P/S ratio	2x
PS Forward	1.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.24%
EBITDA Margin	0.42%
FCF margin	0.47%
Gross margin	62.16%
Gross Profit	$75M
Gross Profit Growth	13.33%
Gross Profit Growth Q	47.91%
Gross Profit Growth3 Y	-9.72%
Gross Profit Growth5 Y	-3.48%
Net Income	$-3.8M
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	-2.41%
Profit Margin	-3.14%
Profit Per Employee	$-16,102
Profitable Quarters	$1
ROA	-1.72
Roa5y	-1.2
ROCE	-3.17
ROE	-2.19
Roe5y	-2.13
ROIC	-4.25
Roic5y	-3.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-9.66%
Cagr15y	7.13%
Cagr1y	61.97%
Cagr20y	2.28%
Cagr3y	-9.06%
Cagr5y	-15.17%
EPS Growth Quarters	1
EPS Growth Years	2
FCF Growth5 Y	-39.38%
OCF Growth	-4.81%
OCF Growth10 Y	-15.24%
OCF Growth5 Y	-10.34%
Revenue Growth	5.33x
Revenue Growth Q	15.56x
Revenue Growth Quarters	3x
Revenue Growth Years	0x
Revenue Growth3 Y	-9.38x
Revenue Growth5 Y	-2.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.65
Assets	$183.5M
Cash	$38.4M
Current Assets	$99.2M
Current Liabilities	$22.1M
Debt	$23.3M
Debt EBITDA	$45.54
Debt Equity	$0.17
Debt FCF	$41.49
Equity	$137.3M
Liabilities	$46.2M
Long Term Assets	$84.3M
Long Term Liabilities	$24M
Net Cash	$15.1M
Net Cash By Market Cap	$6.24
Net Cash Growth	-46.42%
Net Debt EBITDA	$-29.49
Net Debt Equity	$-0.11
Net Debt FCF	$-26.86
Tangible Book Value	$127.8M
Tangible Book Value Per Share	$9.59
WACC	5.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.48
Inventory Turnover	2.01
Net Working Capital	$38.6M
Quick ratio	3.05
Working Capital	$77M
Working Capital Turnover	$1.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	4.23%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-63.8%
1Y total return	61.92%
200-day SMA	12.47
3Y total return	-24.8%
50-day SMA	15.07
50-day SMA vs 200-day SMA	50over200
5Y total return	-56.07%
All Time High	75.72
All Time High Change	-76.13%
All Time High Date	2019-10-25
All Time Low	0.69
All Time Low Change	2,528.36%
All Time Low Date	2000-12-29
ATR	0.85
Beta	0.23
Beta1y	0.67
Beta2y	0.89
Ch YTD	88.03
High	18.58
High52	18.58
High52 Date	2026-07-30
High52ch	-2.74%
Low	16.5
Low52	7.87
Low52 Date	2025-07-31
Low52ch	129.61%
Ma50ch	19.88%
Price vs 200-day SMA	44.87%
RSI	73.94
RSI Monthly	55.86
RSI Weekly	76.07
Sharpe ratio	1.07x
Sortino ratio	1.65
Total Return	4.23%
Tr YTD	88.03
Tr15y	181.03%
Tr1m	20.39%
Tr1w	23.18%
Tr3m	45.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	0
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.01
Earnings Revenue Estimate	29,215,600x
Earnings Revenue Estimate Growth	3.53x
Operating Income	$-5.1M
Operating margin	-4.24
Price target	$21
Price Target Change	$16.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,209,955%
Float Percent	83.76%
Shares Insiders	4.94%
Shares Institutions	74.74%
Shares Out	13,382,966
Shares Qo Q	1.37%
Shares Yo Y	-4.23%
Short Float	3.12%
Short Ratio	4.4
Short Shares	2.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12.6M
Adjusted OCF	-7,170,000
Average Volume	67,631.05x
Bv Per Share	10.3
CAPEX	$-5.4M
Ch10y	-63.8
Ch15y	181
Ch1m	20.39
Ch1w	23.18
Ch1y	61.92
Ch20y	56.99
Ch3m	45.84
Ch3y	-24.8
Ch5y	-56.07
Ch6m	97.49
Change	11.75%
Change From Open	9.45
Close	16.17
Days Gap	2.1
Depreciation Amortization	5,484,000
Dollar Volume	2,067,424.8
Earnings Date	2026-07-29
Earnings Time	bmo
EBIT	$-5.1M
EBITDA	$512,000
EPS	$-0.28
F Score	4
FCF	$562,000
FCF EV Yield	0.25x
FCF Per Share	$0.04
Financing CF	-16,340,000
Fiscal Year End	December
Founded	1,983
Goodwill	7,825,000
Income Tax	$208,000
Investing CF	-4,053,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-29
Last Report Date	2026-06-30
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	13.41
Ma150ch	34.71%
Ma20	15.64
Ma20ch	15.52%
Net CF	-14,755,000
Next Earnings Date	2026-11-04
Open	16.51
Optionable	Yes
P FCF Ratio	430.3
P OCF Ratio	40.46
Position In Range	75.48
Post Close	18.07
Postmarket Change Percent	1.38
Postmarket Price	$18.32
Ppne	65,051,000
Price Date	2026-07-30
Price EBITDA	$472
Ptbv Ratio	1.89
Relative Volume	1.69x
Revenue	120,654,000x
SBC By Revenue	10.9x
Share Based Comp	13,147,000
Tax By Revenue	0.17x
Tr20y	56.99%
Tr6m	97.49%
Us State	Massachusetts
Volume	114,412
Z Score	3.58

Anika Therapeutics, Inc. (ANIK)

Coverage state: Market snapshot only — no published research

Generate the first ANIK analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ANIK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ANIK indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ANIK

Frequently asked questions